It is well accepted that systemic inflammation contributes to CVD and mortality in CKD patients, and some recognized markers of inflammation [interleukin 1 and 6, tumor necrosis factor-alpha (TNFα), and c-reactive protein] are considered possible prognostic factors for CVD in a patient with CKD. The gene discussed is TNF; the disease is chronic kidney disease.